Tucson, AZ (PRWEB) April 04, 2013 </p><p> SynCardia Systems, Inc. (http://www.syncardia.com) the privately-held manufacturer of the worlds first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heartannounced today that its Companion 2 (C2) Driver System, which powers the SynCardia temporary Total Artificial Heart in the hospital, has been selected as one of four finalists in the Critical-Care and Emergency Medicine Products category of the 15th Annual Medical Design Excellence Awards (MDEA). The winners will be announced on June 19 in Philadelphia.</p>
<p>Prior to the development of the C2 Driver, the only FDA-approved driver for powering the Total Artificial Heart in the hospital, was the 418-pound Big Blue driver, said Michael Garippa, SynCardia Chairman/CEO/President. Although Big Blue is extremely reliable, its size and weight reduces patient mobility and there are only 36 available worldwide. The state-of-the-art C2 Driver, which we manufacture and have more than 90 units at SynCardia Certified Centers, is both robust and mobile, supporting very sick patients of all sizes in the operating room and in the hospital during recovery and ambulation.</p>
<p>For the Total Artificial Heart implant, the C2 Driver is docked in the Hospital Cart. Featuring sturdy support handles and locking casters, the Hospital Cart assists patients in standing and walking during their early recovery. Once the patient is out of bed and ambulatory, the C2 Driver can be docked in the Driver Caddy, which provides patients with greater mobility in the hospital and on hospital grounds.</p>
<p>Once stable, patients who are eligible can be switched to the 13.5-pound Freedom
Orignal From: Medical Design Excellence Awards Names SynCardias Companion 2 Driver a Finalist
No comments:
Post a Comment